Non-Surgical Management of Advanced Squamous Cell Carcinoma by a Novel Agent

Track:
Oculoplastics
What:
Paper Presentation | Présentation d'article
When:
2:02 PM, Friday 10 Jun 2022 (7 minutes)
How:

Authors: Ryan Eidsness, Malshi Kurunatilake, Mussawar Iqbal. University of Saskatchewan.

Author Disclosure Block: R. Eidsness: None. M. Kurunatilake: None. M. Iqbal: None

Abstract Body:

Purpose: Discuss a case of advanced Squamous cell carcinoma (SCC) involving the eyelid, conjunctiva, and orbit that responded to Cemiplimab (Libtayo)

Study Design: Study design: Case Study

Methods: A case study of advanced SCC involving eyelids, conjunctiva and orbit was selected for evaluation. The clinical course of outcomes with follow up of >12 months from treatment conclusion are presented
Results: With the use of cemiplimab the eyelid and orbital component of the SCC completely resolved with the cemiplimab and has remained tumor free for >12 months time. The conjunctival component was aided with the use of topical interferon as well as retinoic acid.

Conclusions: We were able to avoid a large disfiguring exenteration and thus salvage the globe and preserve functional vision in the right eye.
 

Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
To respect data privacy rules, this option only displays profiles of attendees who have chosen to share their profile information publicly.